Login Register Cart 0
Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery

Author(s): Francesca Di Candido*

Volume 17, Issue 4, 2022

Published on: 21 September, 2022

Page: [227 - 239] Pages: 13

DOI: 10.2174/1574887117666220811143426

Price: $65

Abstract

Inflammatory Bowel Diseases (IBDs) are chronic, relapsing and disabling diseases that affect the gastrointestinal tract. This relapsing course is often unpredictable with severe flares and the need for intensive medical treatment, hospitalization, or emergent/urgent surgery, all of which significantly impact patients’ quality of life (QoL). QoL in IBD patients is significantly lower than in the general population, and depression and anxiety have been shown to have a higher prevalence than in healthy individuals, especially during disease flares. Complications requiring hospitalization and repeated surgeries are not uncommon during the disease course and significantly affect QoL in IBD patients. Patient-reported outcome measures (PROMs) can be used to measure the impact of chronic disease on QoL from the patient’s perspective. The use of PROMs in IBD patients undergoing surgery could help to investigate the impact of the surgical procedure on QoL and determine whether there is any improvement or worsening. This review summarizes the use of PROMs to assess QoL after various surgical procedures required for IBD treatment.

Keywords: Quality of life, inflammatory bowel disease, patient reported, outcome measure, ulcerative colitis, Crohn’s disease, psychological distress.

« Previous Next »
[1]
Burisch J, Munkholm P,. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015; 50(8): 942-51.
[http://dx.doi.org/10.3109/00365521.2015.1014407] [PMID: 25687629]
[2]
Levine JS,, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011; 7(4): 235-41.
[PMID: 21857821]
[3]
Simian D, Quijada MI, Lubascher J, Acuña R, Quera R. Treatment of inflammatory bowel disease with infliximab: Experience in 25 patients. Rev Med Chil 2013; 141(9): 1158-65.
[http://dx.doi.org/10.4067/S0034-98872013000900008] [PMID: 24522419]
[4]
Cohen RD. The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther 2002; 16(9): 1603-9.
[http://dx.doi.org/10.1046/j.1365-2036.2002.01323.x] [PMID: 12197839]
[5]
Rogala L, Miller N, Graff LA, et al. Population-based controlled study of social support, self-perceived stress, activity and work issues, and access to health care in inflammatory bowel disease. Inflamm Bowel Dis 2008; 14(4): 526-35.
[http://dx.doi.org/10.1002/ibd.20353] [PMID: 18183608]
[6]
LeBlanc K, Mosli MH, Parker CE, MacDonald JK. The impact of biological interventions for ulcerative colitis on health-related quality of life. Cochrane Database Syst Rev 2015; (9): CD008655
[http://dx.doi.org/10.1002/14651858.CD008655.pub3] [PMID: 26393522]
[7]
Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohn’s Colitis 2007; 1(1): 10-20.
[http://dx.doi.org/10.1016/j.crohns.2007.06.005] [PMID: 21172179]
[8]
Filipovic BR, Filipovic BF. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(13): 3552-63.
[http://dx.doi.org/10.3748/wjg.v20.i13.3552] [PMID: 24707138]
[9]
Häuser W, Janke KH,, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: Comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 2011; 17(2): 621-32.
[http://dx.doi.org/10.1002/ibd.21346] [PMID: 20848528]
[10]
Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management. Inflamm Bowel Dis 2009; 15(7): 1105-8.
[http://dx.doi.org/10.1002/ibd.20873] [PMID: 19161177]
[11]
Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol 2010; 105(9): 1994-2002.
[http://dx.doi.org/10.1038/ajg.2010.140] [PMID: 20372115]
[12]
Barnes EL, Kochar B, Long MD, et al. Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database. Inflamm Bowel Dis 2017; 23(6): 875-1.
[http://dx.doi.org/10.1097/MIB.0000000000001121] [PMID: 28426473]
[13]
Ananthakrishnan AN, Gainer VS, Perez RG, et al. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther 2013; 37(4): 445-54.
[http://dx.doi.org/10.1111/apt.12195] [PMID: 23289600]
[14]
Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 1976; 70(3): 439-4.
[http://dx.doi.org/10.1016/S0016-5085(76)80163-1] [PMID: 1248701]
[15]
Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet 1980; 1(8167): 514.
[http://dx.doi.org/10.1016/S0140-6736(80)92767-1] [PMID: 6102236]
[16]
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) Patient-reported outcome measures use in medical product development to support labeling claims 2009. Available from https://www.fda.gov/down-loads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf [Accessed October 10, 2019].
[17]
Mowat C, Cole A, Windsor A, et al. IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60(5): 571-607.
[http://dx.doi.org/10.1136/gut.2010.224154] [PMID: 21464096]
[18]
Beddy D, Dozois EJ, Pemberton JH. Perioperative complications in inflammatory bowel disease. Inflamm Bowel Dis 2011; 17(7): 1610-9.
[http://dx.doi.org/10.1002/ibd.21504] [PMID: 21674718]
[19]
Allison M, Lindsay J, Gould D, Kelly D. Surgery in young adults with inflammatory bowel disease: A narrative account. Int J Nurs Stud 2013; 50(11): 1566-75.
[http://dx.doi.org/10.1016/j.ijnurstu.2013.04.003] [PMID: 23684395]
[20]
Hahnloser D, Pemberton JH,, Wolff BG,, Larson DR,, Crownhart BS,, Dozois RR. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg 2007; 94(3): 333-40.
[http://dx.doi.org/10.1002/bjs.5464] [PMID: 17225210]
[21]
Porter ME. What is value in health care? N Engl J Med 2010; 363(26): 2477-81.
[http://dx.doi.org/10.1056/NEJMp1011024] [PMID: 21142528]
[22]
Bradley SM, Rumsfeld JS, Ho PM. Incorporating health status in routine care to improve health care value: The VA patient reported health status assessment [PROST] system. JAMA 2016; 316(5): 487-8.
[http://dx.doi.org/10.1001/jama.2016.6495] [PMID: 27483062]
[23]
Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012; 61(2): 241-.
[http://dx.doi.org/10.1136/gutjnl-2011-300049] [PMID: 21646246]
[24]
Irvine EJ,, Zhou Q, Thompson AK. The short inflammatory bowel disease questionnaire: A quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn’s Relapse Prevention Trial. Am J Gastroenterol 1996; 91(8): 1571-8.
[PMID: 8759664]
[25]
Yellen SB, Cella DF,, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13(2): 63-74.
[http://dx.doi.org/10.1016/S0885-3924(96)00274-6] [PMID: 9095563]
[26]
Gower-Rousseau C, Sarter H, Savoye G et al, et al. Validation of the inflammatory bowel disease disability index in a population-based cohort. Gut 2015. Epub ahead of print
[http://dx.doi.org/10.1136/gutjnl-2015-310151] [PMID: 26646934]
[27]
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361-70.
[http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x] [PMID: 6880820]
[28]
Bewtra M, Brensinger CM, Tomov VT, et al. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index. Inflamm Bowel Dis 2014; 20(6): 1070-8.
[http://dx.doi.org/10.1097/MIB.0000000000000053] [PMID: 24810138]
[29]
Clara I, Lix LM, Walker JR, et al. The Manitoba IBD Index: Evidence for a new and simple indicator of IBD activity. Am J Gastroenterol 2009; 104(7): 1754-63.
[http://dx.doi.org/10.1038/ajg.2009.197] [PMID: 19455122]
[30]
Khanna R, Zou G, D’Haens G, et al. A retrospective analysis: The development of patient reported outcome measures for the assessment of Crohn’s disease activity. Aliment Pharmacol Ther 2015; 41(1): 77-86.
[http://dx.doi.org/10.1111/apt.13001] [PMID: 25348809]
[31]
Bennebroek Evertsz’ F, Hoeks CC, Nieuwkerk PT,, et al. Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn’s disease activity. J Clin Gastroenterol 2013; 47(10): 850-6.
[http://dx.doi.org/10.1097/MCG.0b013e31828b2196] [PMID: 23632348]
[32]
Bennebroek Evertsz’ F, Nieuwkerk PT,, Stokkers PC,, et al. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers. J Crohn’s Colitis 2013; 7(11): 890-900.
[http://dx.doi.org/10.1016/j.crohns.2012.11.007] [PMID: 23269224]
[33]
Van Deen WK, van der Meulen-de Jong AE, Parekh NK, et al. Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies. Clin Gastroenterol Hepatol 2016; 14(12): 1742-1750.e7.
[http://dx.doi.org/10.1016/j.cgh.2015.10.035] [PMID: 26598228]
[34]
Gürel S, Kiyici M. Ulcerative colitis activity index: A useful prognostic factor for predicting ulcerative colitis outcome. J Int Med Res 2005; 33(1): 103-10.
[http://dx.doi.org/10.1177/147323000503300111] [PMID: 15651722]
[35]
Pontes RM, Miszputen SJ, Ferreira-Filho OF, Miranda C, Ferraz MB. Quality of life in patients with inflammatory bowel diseases: Translation to Portuguese language and validation of the “Inflammatory Bowel Disease Questionnaire” (IBDQ). Arq Gastroenterol 2004; 41(2): 137-43.
[http://dx.doi.org/10.1590/S0004-28032004000200014] [PMID: 15543390]
[36]
Alcalá MJ, Casellas F, Fontanet G, Prieto L, Malagelada JR. Shortened questionnaire on quality of life for inflammatory bowel disease. Inflamm Bowel Dis 2004; 10(4): 383-91.
[http://dx.doi.org/10.1097/00054725-200407000-00009] [PMID: 15475746]
[37]
López-Vivancos J, Casellas F, Badia X, Vilaseca J, Malagelada JR. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn’s disease. Digestion 1999; 60(3): 274-80.
[http://dx.doi.org/10.1159/000007670] [PMID: 10343142]
[38]
Eypasch E, Wood-Dauphinée S, Williams JI, Ure B, Neugebauer E, Troidl H. The gastrointestinal quality of life index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg 1993; 64(4): 264-74.
[PMID: 8482141]
[39]
Kiran RP, Delaney CP, Senagore AJ, et al. Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn’s disease. Am J Gastroenterol 2003; 98(8): 1783-9.
[http://dx.doi.org/10.1111/j.1572-0241.2003.07592.x] [PMID: 12907333]
[40]
Ware JEJ, Snow KK, Kosinski M. SF-36 Health Survey: Manual and interpretation guideBoston, MA. The Health Institute, New England Medical Center 1993.
[41]
Van Assche G, Peyrin-Biroulet L, Sturm A, et al. Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months-Multicenter European cohort study. Dig Liver Dis 2016; 48(6): 592-600.
[http://dx.doi.org/10.1016/j.dld.2016.01.011] [PMID: 26935454]
[42]
Ciconelli RM, Soárez PC,, Kowalski CC, Ferraz MB. The Brazilian Portuguese version of the work productivity and activity impairment: General Health (WPAI-GH) Questionnaire. Sao Paulo Med J 2006; 124(6): 325-32.
[http://dx.doi.org/10.1590/S1516-31802006000600005] [PMID: 17322953]
[43]
Lerdal A, Wahl A, Rustøen T, Hanestad BR, Moum T. Fatigue in the general population: A translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 2005; 33(2): 123-30.
[http://dx.doi.org/10.1080/14034940410028406] [PMID: 15823973]
[44]
Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 2003; 25(4): 277-83.
[http://dx.doi.org/10.1016/S0163-8343(03)00043-4] [PMID: 12850660]
[45]
Buysse DJ, Reynolds CF III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28(2): 193-213.
[http://dx.doi.org/10.1016/0165-1781(89)90047-4] [PMID: 2748771]
[46]
Papi C, Festa V, Fagnani C, et al. Evolution of clinical behaviour in Crohn’s disease: Predictive factors of penetrating complications. Dig Liver Dis 2005; 37(4): 247-53.
[http://dx.doi.org/10.1016/j.dld.2004.10.012] [PMID: 15788208]
[47]
Louis E, Reenaers C, Belaiche J. Does the behavior of Crohn’s disease change over time? Inflamm Bowel Dis 2008; 14 (Suppl. 2): S54-5.
[http://dx.doi.org/10.1097/00054725-200810001-00028] [PMID: 18816690]
[48]
Lakatos PL,, Czegledi Z, Szamosi T, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s disease. World J Gastroenterol 2009; 15(28): 3504-10.
[http://dx.doi.org/10.3748/wjg.15.3504] [PMID: 19630105]
[49]
Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn’s disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6(1): 8-15.
[http://dx.doi.org/10.1097/00054725-200002000-00002] [PMID: 10701144]
[50]
Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A): 5-36.
[51]
Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis 2018; 24(4): 742-51.
[http://dx.doi.org/10.1093/ibd/izx100] [PMID: 29562277]
[52]
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis 2018; 24(5): 966-76.
[http://dx.doi.org/10.1093/ibd/izy015] [PMID: 29688466]
[53]
Cosnes J, Gower–Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140(6): 1785-94.
[http://dx.doi.org/10.1053/j.gastro.2011.01.055]
[54]
Louis E, Reenaers C, Belaiche J. Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn’s disease? Inflamm Bowel Dis 2008; 14 (Suppl. 2): S59-60.
[http://dx.doi.org/10.1097/00054725-200810001-00031] [PMID: 18816759]
[55]
Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: A cross-sectional study of 361 patients in Southern Italy. Eur J Gastroenterol Hepatol 2015; 27(2): 175-81.
[http://dx.doi.org/10.1097/MEG.0000000000000244] [PMID: 25461228]
[56]
Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: A new measure of health status. Psychosom Med 1991; 53(6): 701-12.
[http://dx.doi.org/10.1097/00006842-199111000-00010] [PMID: 1758953]
[57]
de Rooy EC, Toner BB, Maunder RG, et al. Concerns of patients with inflammatory bowel disease: Results from a clinical population. Am J Gastroenterol 2001; 96(6): 1816-21.
[http://dx.doi.org/10.1016/S0002-9270(01)02440-6] [PMID: 11419835]
[58]
Bączyk G, Formanowicz D, Gmerek Ł, Krokowicz P. Health-related quality of life assessment among patients with inflammatory bowel diseases after surgery-review. Prz Gastroenterol 2017; 12(1): 6-16.
[http://dx.doi.org/10.5114/pg.2016.64037] [PMID: 28337230]
[59]
Casellas F, López-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Impact of surgery for Crohn’s disease on health-related quality of life. Am J Gastroenterol 2000; 95(1): 177-82.
[http://dx.doi.org/10.1111/j.1572-0241.2000.01681.x] [PMID: 10638579]
[60]
Jones DW, Finlayson SR. Trends in surgery for Crohn’s disease in the era of infliximab. Ann Surg 2010; 252(2): 307-12.
[http://dx.doi.org/10.1097/SLA.0b013e3181e61df5] [PMID: 20585239]
[61]
Devlen J, Beusterien K, Yen L, Ahmed A, Cheifetz AS, Moss AC. The burden of inflammatory bowel disease: A patient-reported qualitative analysis and development of a conceptual model. Inflamm Bowel Dis 2014; 20(3): 545-52.
[http://dx.doi.org/10.1097/01.MIB.0000440983.86659.81] [PMID: 24407484]
[62]
Lesperance K, Martin MJ, Lehmann R, Brounts L, Steele SR. National trends and outcomes for the surgical therapy of ileocolonic Crohn’s disease: A population-based analysis of laparoscopic vs. open approaches. J Gastrointest Surg 2009; 13(7): 1251-9.
[http://dx.doi.org/10.1007/s11605-009-0853-3] [PMID: 19301075]
[63]
Delaney CP, Kiran RP, Senagore AJ, et al. Quality of life improves within 30 days of surgery for Crohn’s disease. J Am Coll Surg 2003; 196(5): 714-21.
[http://dx.doi.org/10.1016/S1072-7515(03)00131-5] [PMID: 12742203]
[64]
Eshuis EJ, Polle SW, Slors JF, et al. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn’s disease: A comparative study. Dis Colon Rectum 2008; 51(6): 858-67.
[http://dx.doi.org/10.1007/s10350-008-9195-6] [PMID: 18266036]
[65]
Scarpa M, Ruffolo C, D’Incà R, et al. Health-related quality of life after ileocolonic resection for Crohn’s disease: Long-term results. Inflamm Bowel Dis 2007; 13(4): 462-9.
[http://dx.doi.org/10.1002/ibd.20080] [PMID: 17206691]
[66]
Ha FJ, Thong L, Khalil H. Quality of Life after Intestinal Resection in Patients with Crohn Disease: A Systematic Review. Dig Surg 2017; 34(5): 355-63.
[http://dx.doi.org/10.1159/000453590] [PMID: 28099962]
[67]
Wright EK, Kamm MA, De Cruz P, et al. Effect of intestinal resection on quality of life in Crohn’s disease. J Crohn’s Colitis 2015; 9(6): 452-62.
[http://dx.doi.org/10.1093/ecco-jcc/jjv058] [PMID: 25855073]
[68]
D’Ugo S, Romano F, Sibio S, et al. Impact of surgery on quality of life in Crohn’s disease: Short-and mid-term follow-up Updates Surg 2020; 72(3): 773-80.
[http://dx.doi.org/10.1007/s13304-020-00738-1] [PMID: 32185677]
[69]
Diederen K, de Ridder L, van Rheenen P, et al. Quality of life and colorectal function in Crohn’s disease patients that underwent ileocecal resection during childhood. Eur J Pediatr 2019; 178(9): 1413-21.
[http://dx.doi.org/10.1007/s00431-019-03427-3] [PMID: 31327075]
[70]
Gajendran M, Bauer AJ, Buchholz BM, et al. Ileocecal anastomosis type significantly influences long-term functional status, quality of life, and healthcare utilization in postoperative Crohn’s Disease patients independent of inflammation recurrence. Am J Gastroenterol 2018; 113(4): 576-83.
[http://dx.doi.org/10.1038/ajg.2018.13] [PMID: 29610509]
[71]
McClane SJ, Rombeau JL. Anorectal Crohn’s disease. Surg Clin North Am 2001; 81(1): 169-83. ix.
[http://dx.doi.org/10.1016/S0039-6109(05)70279-6] [PMID: 11218163]
[72]
Adamina M, Bonovas S, Raine T, et al. ECCO guidelines on therapeutics in Crohn’s Disease: Surgical treatment. J Crohn’s Colitis 2020; 14(2): 155-68.
[http://dx.doi.org/10.1093/ecco-jcc/jjz187] [PMID: 31742338]
[73]
Tekkis PP, Purkayastha S, Lanitis S, et al. A comparison of segmental vs subtotal/total colectomy for colonic Crohn’s disease: A meta-analysis. Colorectal Dis 2006; 8(2): 82-90.
[http://dx.doi.org/10.1111/j.1463-1318.2005.00903.x] [PMID: 16412066]
[74]
Andersson P, Olaison G, Hallböök O, Sjödahl R. Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 2002; 45(1): 47-53.
[http://dx.doi.org/10.1007/s10350-004-6113-4] [PMID: 11786764]
[75]
Kiran RP, Nisar PJ,, Church JM, Fazio VW. The role of primary surgical procedure in maintaining intestinal continuity for patients with Crohn’s colitis. Ann Surg 2011; 253(6): 1130-5.
[http://dx.doi.org/10.1097/SLA.0b013e318212b1a4] [PMID: 21394010]
[76]
Geoghegan JG, Carton E, O’Shea AM, et al. Crohn’s colitis: The fate of the rectum. Int J Colorectal Dis 1998; 13(5-6): 256-9.
[http://dx.doi.org/10.1007/PL00013741] [PMID: 9870172]
[77]
Harling H, Hegnhøj J, Rasmussen TN, Jarnum S. Fate of the rectum after colectomy and ileostomy for Crohn’s colitis. Dis Colon Rectum 1991; 34(10): 931-5.
[http://dx.doi.org/10.1007/BF02049711] [PMID: 1914729]
[78]
American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn’s disease. Gastroenterology 2003; 125(5): 1503-7.
[PMID: 14598267]
[79]
Siassi M, Weiger A, Hohenberger W, Kessler H. Changes in surgical therapy for Crohn’s disease over 33 years: A prospective longitudinal study. Int J Colorectal Dis 2007; 22(3): 319-24.
[http://dx.doi.org/10.1007/s00384-006-0150-5] [PMID: 16733647]
[80]
Fazio VW, Kiran RP, Remzi FH, et al. Ileal pouch anal anastomosis: Analysis of outcome and quality of life in 3707 patients. Ann Surg 2013; 257(4): 679-85.
[http://dx.doi.org/10.1097/SLA.0b013e31827d99a2] [PMID: 23299522]
[81]
Li Y, Stocchi L, Mu X, Cherla D, Remzi FH. Long-term Outcomes of Sphincter-Saving Procedures for Diffuse Crohn’s Disease of the Large Bowel. Dis Colon Rectum 2016; 59(12): 1183-90.
[http://dx.doi.org/10.1097/DCR.0000000000000706] [PMID: 27824704]
[82]
Lavryk OA, Hull TL. Comparison of long-term outcomes of primary and redo IPAA for patients with Crohn’s disease. Int J Colorectal Dis 2019; 34(11): 1945-51.
[http://dx.doi.org/10.1007/s00384-019-03411-1] [PMID: 31667589]
[83]
Kock NG. Intra-abdominal “reservoir” in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal “continence” in five ileostomy patients. Arch Surg 1969; 99(2): 223-31.
[http://dx.doi.org/10.1001/archsurg.1969.01340140095014] [PMID: 5794896]
[84]
Aytac E, Dietz DW, Ashburn J, Remzi FH. Long-term outcomes after continent ileostomy creation in patients with Crohn’s Disease. Dis Colon Rectum 2017; 60(5): 508-13.
[http://dx.doi.org/10.1097/DCR.0000000000000815] [PMID: 28383450]
[85]
Ingle SB, Loftus EV Jr. The natural history of perianal Crohn’s disease. Dig Liver Dis 2007; 39(10): 963-9.
[http://dx.doi.org/10.1016/j.dld.2007.07.154] [PMID: 17720635]
[86]
Singh B. McC Mortensen NJ, Jewell DP, George B. Perianal Crohn’s disease. Br J Surg 2004; 91(7): 801-14.
[http://dx.doi.org/10.1002/bjs.4613] [PMID: 15227686]
[87]
Riss S, Schwameis K, Mittlböck M, et al. Sexual function and quality of life after surgical treatment for anal fistulas in Crohn’s disease. Tech Coloproctol 2013; 17(1): 89-94.
[http://dx.doi.org/10.1007/s10151-012-0890-x] [PMID: 22956209]
[88]
Maconi G, Gridavilla D, Viganò C, et al. Perianal disease is associated with psychiatric co-morbidity in Crohn’s disease in remission. Int J Colorectal Dis 2014; 29(10): 1285-90.
[http://dx.doi.org/10.1007/s00384-014-1935-6] [PMID: 24986138]
[89]
Irvine EJ. Usual therapy improves perianal Crohn’s disease as measured by a new disease activity index. McMaster IBD Study Group J Clin Gastroenterol 1995; 20(1): 27-32.
[http://dx.doi.org/10.1097/00004836-199501000-00008] [PMID: 7884173]
[90]
Adegbola SO, Dibley L, Sahnan K, et al. Burden of disease and adaptation to life in patients with Crohn’s perianal fistula: A qualitative exploration. Health Qual Life Outcomes 2020; 18(1): 370.
[http://dx.doi.org/10.1186/s12955-020-01622-7] [PMID: 33218361]
[91]
Adegbola SO, Dibley L, Sahnan K, et al. Development and initial psychometric validation of a patient-reported outcome measure for Crohn’s perianal fistula: The Crohn’s Anal Fistula Quality of Life (CAF-QoL) scale. Gut 2020.
[http://dx.doi.org/10.1136/gutjnl-2019-320553]
[92]
Nordin K, Påhlman L, Larsson K, Sundberg-Hjelm M, Lööf L. Health-related quality of life and psychological distress in a population-based sample of Swedish patients with inflammatory bowel disease. Scand J Gastroenterol 2002; 37(4): 450-7.
[http://dx.doi.org/10.1080/003655202317316097] [PMID: 11989837]
[93]
Abdalla MI, Sandler RS, Kappelman MD, et al. The Impact of Ostomy on Quality of Life and Functional Status of Crohn’s Disease Patients. Inflamm Bowel Dis 2016; 22(11): 2658-64.
[http://dx.doi.org/10.1097/MIB.0000000000000930] [PMID: 27661669]
[94]
Jansen F, van Uden-Kraan CF, Braakman JA, van Keizerswaard PM,, Witte BI, Verdonck-de Leeuw IM. A mixed-method study on the generic and ostomy-specific quality of life of cancer and non-cancer ostomy patients. Support Care Cancer 2015; 23(6): 1689-97.
[http://dx.doi.org/10.1007/s00520-014-2528-1] [PMID: 25430480]
[95]
Dibley L, Czuber-Dochan W, Wade T, et al. Members of the stoma PPI team. Patient decision-making about emergency and planned stoma surgery for IBD: A Qualitative exploration of patient and clinician perspectives. Inflamm Bowel Dis 2018; 24(2): 235-46.
[http://dx.doi.org/10.1093/ibd/izx043] [PMID: 29361098]
[96]
Shivashankar R, Tremaine WJ, Harmsen WS, Loftus EV Jr. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010. Clin Gastroenterol Hepatol 2017; 15(6): 857-63.
[http://dx.doi.org/10.1016/j.cgh.2016.10.039] [PMID: 27856364]
[97]
Molodecky NA, Soon IS, Rabi DM,, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
[http://dx.doi.org/10.1053/j.gastro.2011.10.001]
[98]
Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012; 143: 1179-87.
[99]
Jairath V, Khanna R, Zou GY, et al. Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials. Aliment Pharmacol Ther 2015; 42(10): 1200-10.
[http://dx.doi.org/10.1111/apt.13408] [PMID: 26388424]
[100]
Yarlas A, Rubin DT, Panés J, et al. Burden of Ulcerative Colitis on Functioning and Well-being: A Systematic Literature Review of the SF-36® Health Survey. J Crohn’s Colitis 2018; 12(5): 600-9.
[http://dx.doi.org/10.1093/ecco-jcc/jjy024] [PMID: 29718244]
[101]
Bohl JL, Sobba K. Indications and options for surgery in ulcerative colitis. Surg Clin North Am 2015; 95(6): 1211-32. vi.
[http://dx.doi.org/10.1016/j.suc.2015.07.003 ] [PMID: 26596923]
[102]
Peyrin-Biroulet L, Germain A, Patel AS, Lindsay JO. Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis. Aliment Pharmacol Ther 2016; 44(8): 807-16.
[http://dx.doi.org/10.1111/apt.13763] [PMID: 27534519]
[103]
Scarpa M, Ruffolo C, Boetto R, Pozza A, Sadocchi L, Angriman I. Diverting loop ileostomy after restorative proctocolectomy: Predictors of poor outcome and poor quality of life. Colorectal Dis 2010; 12(9): 914-20.
[http://dx.doi.org/10.1111/j.1463-1318.2009.01884.x] [PMID: 19508537]
[104]
Heikens JT, de Vries J, van Laarhoven CJ. Quality of life, health-related quality of life and health status in patients having restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: A systematic review. Colorectal Dis 2012; 14(5): 536-44.
[http://dx.doi.org/10.1111/j.1463-1318.2010.02538.x] [PMID: 21176062]
[105]
Lightner AL, Mathis KL, Dozois EJ, et al. Results at Up to 30 Years After Ileal Pouch-Anal anastomosis for chronic ulcerative colitis. Inflamm Bowel Dis 2017; 23(5): 781-90.
[http://dx.doi.org/10.1097/MIB.0000000000001061] [PMID: 28301429]
[106]
Leowardi C, Hinz U, Tariverdian M, et al. Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis. Langenbecks Arch Surg 2010; 395(1): 49-56.
[http://dx.doi.org/10.1007/s00423-009-0479-7] [PMID: 19280217]
[107]
McKenna NP, Mathis KL, Pemberton JH, Lightner AL. The Impact of age at time of ileal pouch anal anastomosis on short and long-term outcomes in adults. Inflamm Bowel Dis 2018; 24(8): 1857-65.
[http://dx.doi.org/10.1093/ibd/izy087] [PMID: 29718243]
[108]
Kjaer MD, Laursen SB, Qvist N, Kjeldsen J, Poornoroozy PH. Sexual function and body image are similar after laparoscopy-assisted and open ileal pouch-anal anastomosis. World J Surg 2014; 38(9): 2460-5.
[http://dx.doi.org/10.1007/s00268-014-2557-4] [PMID: 24711157]
[109]
Browne C, Shaikh F, Iqbal N, McGovern B, Rowe S, Neary P. Quality of life, continence and frequency of pouchitis following laparoscopic versus open colectomy and ileal pouch-anal anastomosis: An Irish perspective. Ir J Med Sci 2015; 184(3): 655-8.
[http://dx.doi.org/10.1007/s11845-014-1233-x] [PMID: 25422064]
[110]
Hicks CW, Hodin RA, Savitt L, Bordeianou L. Does intramesorectal excision for ulcerative colitis impact bowel and sexual function when compared with total mesorectal excision? Am J Surg 2014; 208(4): 499-504.e4.
[http://dx.doi.org/10.1016/j.amjsurg.2014.05.012] [PMID: 25124292]
[111]
Lee GC, Deery SE, Kunitake H, et al. Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis. Int J Colorectal Dis 2019; 34(3): 491-9.
[http://dx.doi.org/10.1007/s00384-018-03221-x] [PMID: 30610435]
[112]
Ishii H, Kawai K, Hata K, et al. Comparison of functional outcomes of patients who underwent hand-sewn or stapled ileal pouch-anal anastomosis for ulcerative colitis. Int Surg 2015; 100(7-8): 1169-76.
[http://dx.doi.org/10.9738/INTSURG-D-15-00012.1] [PMID: 26595489]
[113]
Lavryk OA, Hull TL, Duraes LC, et al. Outcomes of ileal pouch-anal anastomosis without primary diverting loop ileostomy if postoperative sepsis develops. Tech Coloproctol 2018; 22(1): 37-44.
[http://dx.doi.org/10.1007/s10151-017-1737-2] [PMID: 29285681]
[114]
Lorenzo G, Maurizio C, Maria LP, et al. Ileal pouch-anal anastomosis 20 years later: Is it still a good surgical option for patients with ulcerative colitis? Int J Colorectal Dis 2016; 31(12): 1835-43.
[http://dx.doi.org/10.1007/s00384-016-2657-8] [PMID: 27682647]
[115]
Scoglio D, Ahmed Ali U, Fichera A. Surgical treatment of ulcerative colitis: Ileorectal vs ileal pouch-anal anastomosis. World J Gastroenterol 2014; 20(37): 13211-8.
[http://dx.doi.org/10.3748/wjg.v20.i37.13211] [PMID: 25309058]
[116]
da Luz Moreira A, Kiran RP, Lavery I. Clinical outcomes of ileorectal anastomosis for ulcerative colitis. Br J Surg 2010; 97(1): 65-9.
[http://dx.doi.org/10.1002/bjs.6809] [PMID: 20013930]
[117]
Abdalla M, Norblad R, Olsson M, et al. Anorectal function after ileo-rectal anastomosis is better than pelvic pouch in selected ulcerative colitis patients. Dig Dis Sci 2020; 65(1): 250-9.
[http://dx.doi.org/10.1007/s10620-019-05757-6] [PMID: 31372911]
[118]
Tonelli F, Di Martino C, Giudici F. Could total colectomy with ileorectal anastomosis be an alternative to total proctocolectomy with ileal pouch-anal anastomosis in selected ulcerative colitis patients? Gastroenterol Res Pract 2016.20165832743
[http://dx.doi.org/10.1155/2016/5832743] [PMID: 27843448]
[119]
de Buck van Overstraeten A, Brar MS, Khorasani S, Dossa F, Myrelid P. Ileorectal anastomosis versus IPAA for the surgical treatment of ulcerative colitis: A markov decision analysis. Dis Colon Rectum 2020; 63(9): 1276-84.
[http://dx.doi.org/10.1097/DCR.0000000000001686] [PMID: 32472777]
[120]
Aytac E, Ashburn J, Dietz DW. Is there still a role for continent ileostomy in the surgical treatment of inflammatory bowel disease? Inflamm Bowel Dis 2014; 20(12): 2519-.
[http://dx.doi.org/10.1097/MIB.0000000000000160] [PMID: 25222659]
[121]
Owczarek D, Rodacki T, Domagała-Rodacka R, Cibor D, Mach T. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 2016; 22(3): 895-905.
[http://dx.doi.org/10.3748/wjg.v22.i3.895] [PMID: 26811635]
[122]
Dixon LJ, Kabi A, Nickerson KP, McDonald C. Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2015; 21(4): 912-22.
[http://dx.doi.org/10.1097/MIB.0000000000000289] [PMID: 25581832]
[123]
Uranga JA, López-Miranda V, Lombó F, Abalo R. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease. Pharmacol Rep 2016; 68(4): 816-26.
[http://dx.doi.org/10.1016/j.pharep2.16.05.002] [PMID: 27267792]
[124]
Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, et al. Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database Syst Rev 2019; 2(2)CD012839
[http://dx.doi.org/10.1002/14651858.CD012839.pub2] [PMID: 30736095]
[125]
Malinowski B, Wiciński M, Sokołowska MM, Hill NA, Szambelan M. The rundown of dietary supplements and their effects on inflammatory bowel disease-a review. Nutrients 2020; 12(5): 1423.
[http://dx.doi.org/10.3390/nu12051423] [PMID: 32423084]
[126]
Dong J, Chen Y, Tang Y, et al. Body mass index is associated with inflammatory Bowel Disease: A systematic review and meta-analysis. PLoS One 2015; 10(12)e0144872
[http://dx.doi.org/10.1371/journal.pone.0144872] [PMID: 26658675]
[127]
Fink C, Karagiannides I, Bakirtzi K, Pothoulakis C. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 2012; 18(8): 1550-7.
[http://dx.doi.org/10.1002/ibd.22893] [PMID: 22407798]
[128]
Biedermann L, Mwinyi J, Scharl M, et al. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis-an open pilot study. J Crohn’s Colitis 2013; 7(4): 271-9.
[http://dx.doi.org/10.1016/j.crohns.2012.07.010] [PMID: 22883440]
[129]
Burke DA, Axon AT. Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol 1987; 40(7): 782-6.
[http://dx.doi.org/10.1136/jcp4,.7.782] [PMID: 3305586]
[130]
Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn’s disease. Dig Dis Sci 1997; 42(4): 817-22.
[http://dx.doi.org/10.1023/A:1018876400528] [PMID: 9125655]
[131]
Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol 2017; 14(8): 491-502.
[http://dx.doi.org/10.1038/nrgastro.2017.75]
[132]
Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review. J Cell Physiol 2018; 233(3): 2091-103.
[http://dx.doi.org/10.1002/jcp2,911] [PMID: 28294322]
[133]
Derwa Y, Gracie DJ, Hamlin PJ,, Ford AC. Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 2017; 46(4): 389-400.
[http://dx.doi.org/10.1111/apt.14203] [PMID: 28653751]
[134]
Fedorak RN, Feagan BG, Hotte N, et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn’s disease. Clin Gastroenterol Hepatol 2015; 13(5): 928-35.e2.
[http://dx.doi.org/10.1016/j.cgh.2014.10.031] [PMID: 25460016]
[135]
Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial. Gastroenterology 2003; 124(5): 1202-9.
[http://dx.doi.org/10.1016/S0016-5085(03)00171-9] [PMID: 12730861]
[136]
Rufino MN, da Costa AL, Jorge EN, et al. Synbiotics improve clinical indicators of ulcerative colitis: Systematic review with meta-analysis. Nutr Rev 2022; 80(2): 157-64.
[http://dx.doi.org/10.1093/nutrit/nuab017] [PMID: 34010402]
[137]
Kaur L, Gordon M, Baines PA,, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2020; 3(3)CD005573
[http://dx.doi.org/10.1002/14651858.CD005573.pub3] [PMID: 32128795]

Rights & Permissions Print Cite
Article Metrics
5
© 2024 Bentham Science Publishers | Privacy Policy